Elosulfase alfa

From WikiMD.org
Jump to navigation Jump to search

Elosulfase alfa

Elosulfase alfa (pronounced as eh-loh-SUL-fase AL-fa) is a medication used in the treatment of Mucopolysaccharidosis IV (MPS IV), also known as Morquio Syndrome. It is an enzyme replacement therapy that works by replacing the deficient enzyme, N-acetylgalactosamine-6-sulfatase, in patients with MPS IV.

Etymology

The name 'Elosulfase alfa' is derived from the enzyme it replaces, N-acetylgalactosamine-6-sulfatase. The 'alfa' denotes that it is a form of the enzyme produced through recombinant DNA technology.

Usage

Elosulfase alfa is used to treat patients with Mucopolysaccharidosis IV, a rare genetic disorder characterized by the body's inability to break down certain sugars and proteins. This leads to a buildup of these substances in the body, causing various health problems. By replacing the deficient enzyme, Elosulfase alfa helps to reduce the symptoms of MPS IV.

Related Terms

  • Enzyme replacement therapy: A treatment method that involves replacing a missing or deficient enzyme in patients with certain genetic disorders.
  • Mucopolysaccharidosis: A group of metabolic disorders caused by the absence or malfunctioning of certain enzymes needed to break down molecules called glycosaminoglycans.
  • Morquio Syndrome: Another name for Mucopolysaccharidosis IV, named after the doctor who first described the condition.
  • N-acetylgalactosamine-6-sulfatase: The enzyme that is deficient in patients with Mucopolysaccharidosis IV.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski